Review Article: Predictors of Response to Vedolizumab and Ustekinumab in Inflammatory Bowel Disease
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.14550
Full Text
Open PDFAbstract
Available in full text
Date
February 12, 2018
Authors
Publisher
Wiley